Allosteric properties of G protein-coupled receptor oligomers.
about
Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei--serpentine gateways to neuroendocrine homeostasisAllostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapesMarked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptorsHarmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activationSweet taste receptor gene variation and aspartame taste in primates and other speciesTrans-activation between 7TM domains: implication in heterodimeric GABAB receptor activationFunctional characterization of G-protein-coupled receptors: a bioinformatics approach.On the fitting of binding data when receptor dimerization is suspected.V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH.Direct interaction of GABAB receptors with M2 muscarinic receptors enhances muscarinic signaling.An in vivo demonstration of functional G protein-coupled receptor dimers.Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain.Relationship between homo-oligomerization of a mammalian olfactory receptor and its activation state demonstrated by bioluminescence resonance energy transfer.CODA-RET reveals functional selectivity as a result of GPCR heteromerization.Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics.Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling.A new approach for studying GPCR dimers: drug-induced inactivation and reactivation to reveal GPCR dimer function in vitro, in primary culture, and in vivoDual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signalingMisfolding Ectodomain Mutations of the Lutropin Receptor Increase Efficacy of Hormone StimulationIdentification of non-lipid LPA3 antagonists by virtual screening.Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4.Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1aImaging chemokine receptor dimerization with firefly luciferase complementation.Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization.Heterodimerization between the lutropin and follitropin receptors is associated with an attenuation of hormone-dependent signaling.Caged naloxone reveals opioid signaling deactivation kinetics.G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists.Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors.G protein-coupled receptors: walking hand-in-hand, talking hand-in-hand?Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systems.Moonlighting adenosine deaminase: a target protein for drug development.Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A.Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation.CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer.G protein activation by the leukotriene B4 receptor dimer. Evidence for an absence of trans-activation.Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer.Actin cytoskeleton-dependent regulation of corticotropin-releasing factor receptor heteromers.Enhanced ZnR/GPR39 Activity in Breast Cancer, an Alternative Trigger of Signaling Leading to Cell Growth.
P2860
Q24630645-89572597-B78C-43BE-990C-9372AD41E0E4Q24633335-F5F91A9D-CB6D-46C1-9CCB-B6C4D8B9FA3FQ24633877-709F0B8E-5990-458B-BD92-BA9FD1D8373EQ24644889-6A4F8F2E-E425-42FF-8144-589EAFB5F750Q24656036-CE8DDB33-AA76-45F6-A105-1B1D8835AD32Q28388576-18BDFDEB-6938-4507-B5E8-BCE78EF97627Q28576041-F186712B-FE1E-4217-ABA5-A658175C6C0AQ30009384-383FDFCD-3F8C-47AF-9972-DF62B391CEE2Q31158245-B1766879-F490-4565-8817-73D30B8B2123Q33636647-B264DE5F-1ECF-4B5E-AAFB-60FBF56AB617Q33637415-DB4DAAF2-F051-4A15-BA68-44E161D0C68EQ33720008-F19D89C6-9CE2-4212-A4D8-20C8069C813EQ34524896-FADE69DB-BEF0-4ACB-B2F8-20F111E27611Q34868690-AA183072-2E41-4BC0-932B-B5672E142F62Q35171170-53B7867C-EB98-4912-8ECF-EB964AEF0B06Q35225057-01D18DA3-EED2-4BAB-99B6-57ED2D6872AFQ35225069-F082474C-CDB0-4CC9-9C70-777FA068953BQ35713438-2C795ADF-27F2-44AB-A570-25BA0D22382DQ35738220-F62A46FF-28E5-41D4-BD7F-0E4A0D29645DQ36415775-20A218E9-7A1D-4030-BD5F-C9E83C41DB6DQ36789822-23D4F689-88D2-4BA3-9257-94F24656691EQ36949065-D5FEA6E8-9468-4F52-A3C3-1C904ABE1800Q37016373-8D05FBBB-EB51-40F3-BAD0-8B4B7E70CC08Q37123955-B5E355EA-295F-429A-9E7D-000AEBD544BCQ37134357-14FC9864-5AF2-4C48-8974-EC6617BB68B4Q37181882-C906E262-1825-4205-9EE2-608943766EF7Q37252077-63DE42B9-F6EB-48EF-BB7E-E0635BF7F3A1Q37421818-07D1D00A-A82A-4795-AA0E-2D6C1560D013Q37431503-DC2C0FF8-C6C8-4C12-971B-6C9295524D86Q37455434-A0B421C4-0B26-4DE1-862C-91E1933BA037Q37829756-AB99324D-BC96-44B7-8666-F7D5575AEBE2Q38014940-2DF6AD3B-9E74-40E1-AE68-4480BF1E354DQ38220597-10271CD1-4FB1-4BBB-BEAB-A54BCB339220Q38795549-EEA9D423-1433-4484-A8A6-43867E58FDBDQ39817865-382208F8-C77E-4C2A-89CC-3D3F50CCA29EQ40007873-F7434F29-1E57-4ABD-9EA4-87362EBC5A17Q40422401-191BD8C4-D83F-45C1-9A9D-1A6A238BB5D6Q41694901-A5D19A81-7638-452E-BFFF-97A913593C92Q43491697-1E4B816B-CA29-4FE3-91C0-E6C77861A42CQ55119860-ED8E2AED-CAA2-4D0F-9B07-F08E34168BD6
P2860
Allosteric properties of G protein-coupled receptor oligomers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Allosteric properties of G protein-coupled receptor oligomers.
@en
type
label
Allosteric properties of G protein-coupled receptor oligomers.
@en
prefLabel
Allosteric properties of G protein-coupled receptor oligomers.
@en
P2093
P1476
Allosteric properties of G protein-coupled receptor oligomers.
@en
P2093
Eneko Urizar
Gilbert Vassart
Jean-Yves Springael
Marc Parmentier
Sabine Costagliola
P304
P356
10.1016/J.PHARMTHERA.2007.06.004
P577
2007-06-27T00:00:00Z